EAHAD-EHA-EHC Joint Support Statement on the EMA draft Guideline for
the clinical requirements for non-replacement therapy in haemophilia A and B
For the last thirty years, haemophilia A and B patients have been treated using FVIII and FIX replacement concentrates. These therapies are well known to both clinicians and patients. We are now entering a new…
Cell and Gene Therapy Summit 2024
April 15th and 16th 2024, Brussels Cell and gene therapies will reshape healthcare, but when? With advances in technology and many innovative treatments on the horizon, cell and gene therapies can reshape healthcare, giving hope to patients who previously had no therapeutic options. But when will their potential…
EAHAD Gene Therapy Webinar: Global distribution of gene therapy
Join us for an exploration of the global landscape of Gene Therapy with the upcoming webinar "Global Distribution of Gene Therapy" organized by the EAHAD Gene Therapy Working Group. Delve into a comprehensive overview of how various countries manage gene therapy, focusing particularly on Europe and the…
2024 EAHAD Research Grants cycle now open
We are very happy to announce that the 2024 EAHAD Research Grants cycle is now open. The EAHAD Research Grant Awards have been initiated with an aim to foster pre-clinical and clinical research collaborations in Europe and support scientific projects with the objective of improving the care of…
Join us for the second E-Learning Live Discussion on the EAHAD Academy on 26 October 2023!
Luciano Baronciani, Omid Seidizadeh, Flora Peyvandi, Roberta Gualtierotti, and Sophie Susen will share their insights and knowledge on various topics related to von Willebrand Disease. The event will focus on delving deeper into the topics covered in modules 4, 5, and 6…
Join the EAHAD Social Media Ambassadors Programme for EAHAD 2024!
APPLY NOW
The Social Media Ambassador Programme aims to enhance EAHAD’s mission of ensuring the provision of the highest quality of clinical care, educating the medical community and the general public, and promoting scientific research in the field of haemophilia and allied disorders. Mission & Goals…
The Annual Report for 2022 is now available!
We are thrilled to announce that the Annual Report for 2022 is now available! In the EAHAD Annual Report 2022, you will find a comprehensive overview of all the key activities carried out by our association and achievements accomplished throughout the year.
CHECK IT NOW
Join us for the Gene Therapy in Haemophilia webinar “Relevance of anti-AAV antibodies testing in haemophilia gene therapy”
During the webinar, our speakers will delve into the crucial role of anti-AAV antibodies testing in the context of gene therapy for haemophilia, sheding light on the significance of pre-treatment testing, the challenges faced in laboratory…
Request for Proposals (RFP) to Host Annual EAHAD Congress 2026
Are you a clinician actively involved in the haemophilia and bleeding disorders field? Or perhaps you are a dedicated member of EAHAD? If so, we have an exciting opportunity for you to consider. The EAHAD is currently accepting Request for Proposals (RFP) to host the…
Are you ready to take your understanding of haemophilia management to the next level? Rewatch the first e-learning live event, in which our speakers Robert Klamroth, Cedric Hermans, Carmen Escuriola-Ettingshausen, Christoph Konigs, and Jan Astermark delved deeper into the captivating topics covered in Modules 1, 2, and 3.
Hosted by Yesim Dargaud, this live event was an invaluable opportunity to gain insight into…
